According to Fortune Business Insights, the global heart failure monitoring devices market size was valued at USD 8.20 billion in 2025 and is projected to grow from USD 8.84 billion in 2026 to USD 15.82 billion by 2034, registering a CAGR of 7.5% during 2026โ2034. The market is gaining momentum as healthcare providers increasingly adopt technologies that can monitor cardiac function, fluid levels, heart rate, blood pressure, oxygen saturation, and other vital parameters. The growing burden of heart failure, aging populations, demand for early detection, and efforts to reduce hospital readmissions are supporting market expansion.
What Are Heart Failure Monitoring Devices?
Heart failure monitoring devices are medical technologies designed to track physiological parameters associated with heart function and worsening heart failure. These systems help physicians identify changes in a patient's condition and support timely clinical intervention.
Depending on the technology, monitoring may be performed continuously or periodically. Devices range from hospital-based external monitoring systems to wearable technologies and implantable hemodynamic monitoring devices.
The increasing shift toward patient-centered and home-based care is also expanding the role of these devices beyond conventional hospital environments.
Heart Failure Monitoring Devices Market Overview
The market is developing alongside the broader transformation of cardiovascular care. Healthcare systems are increasingly emphasizing early intervention rather than waiting until patients experience severe symptoms that require hospitalization.
Fortune Business Insights identifies several factors supporting market growth, including the rising heart failure patient population, increasing prevalence of diabetes, hypertension, obesity, and sedentary lifestyles, as well as the need to reduce costly hospital readmissions.
In addition, remote patient monitoring and telehealth infrastructure are creating new opportunities for devices that can collect patient data outside traditional healthcare facilities.
Heart Failure Monitoring Devices Market Growth Drivers
Rising Burden of Heart Failure
The growing prevalence of heart failure represents one of the most important growth drivers for monitoring technologies. Patients with heart failure may experience changes in fluid levels, cardiac pressure, heart rate, and other physiological parameters before their condition becomes clinically severe.
Monitoring systems can help healthcare professionals recognize these changes earlier and adjust treatment when appropriate.
Fortune Business Insights notes that around 6.7 million U.S. adults over age 20 currently have heart failure, with prevalence projected to reach approximately 8.5 million by 2030, according to the Heart Failure Society of America.
Growing Need to Reduce Hospital Readmissions
Repeated hospitalizations place considerable pressure on healthcare systems and patients. Monitoring devices can support ongoing disease management by providing clinicians with information about a patient's condition.
This is particularly important as healthcare providers increasingly focus on preventive care, early intervention, and reducing avoidable hospital visits.
Older adults have a higher risk of cardiovascular diseases and chronic conditions that can contribute to heart failure. As populations age across developed and emerging economies, demand for continuous monitoring technologies is expected to increase.
Wearable and home-based systems can also provide practical solutions for elderly patients who require regular monitoring without frequent hospital visits.
Integration of AI and Predictive Analytics Is a Major Market Trend
The integration of artificial intelligence (AI) and predictive analytics is emerging as a significant trend in the heart failure monitoring devices market.
Modern monitoring platforms can collect multiple data points and use advanced analytics to identify patterns that may indicate deterioration. Predictive technologies can potentially provide earlier alerts and help clinicians prioritize patients who require attention.
Fortune Business Insights highlights the growing integration of AI and predictive analytics into monitoring systems. The report also notes that advanced wearable technologies are enabling continuous monitoring with improved accuracy and supporting clinical decision-making.
This trend is likely to become increasingly important as healthcare providers manage larger volumes of patient-generated data.
Expansion of Remote Patient Monitoring
Remote patient monitoring is creating another important growth opportunity for market participants. Telehealth infrastructure allows healthcare providers to monitor selected patients outside conventional clinical environments.
The expansion of home-based care can increase demand for wearable and non-invasive monitoring devices capable of transmitting physiological data to healthcare professionals.
Fortune Business Insights identifies the expansion of remote patient monitoring programs as a significant market opportunity and notes increasing investment in AI, cloud platforms, and connected monitoring technologies.
Emerging markets, including India, Brazil, and Southeast Asian countries, are also developing telemedicine infrastructure, creating additional opportunities for remote cardiac monitoring.
Segmentation of the Heart Failure Monitoring Devices Market
The market is segmented by device type, mode, end-user, and region.
Based on device type, the market is divided into:
Implantable hemodynamic monitoring devices
Wearable monitoring devices
External/non-wearable monitoring systems
The external/non-wearable monitoring systems segment held the largest market share in 2025. Their widespread use in hospitals, bedside monitoring environments, and emergency settings supports the segment's position.
Meanwhile, wearable monitoring devices are expected to experience strong growth, with Fortune Business Insights projecting a 7.8% CAGR for the segment during the forecast period.
Based on mode, the market is categorized into:
The non-invasive segment dominated the market and is estimated to account for 85.2% of the market in 2026. These devices can monitor parameters such as blood pressure, oxygen levels, and heart rate without requiring surgical intervention.
The preference for patient comfort, safety, and easier monitoring is expected to continue supporting demand for non-invasive technologies.
Based on end user, the market includes:
Hospitals & ASCs
Specialty clinics
Homecare settings
Long-term care & others
Hospitals & ASCs represented the leading end-user segment in 2025 and are expected to account for 45.4% of the market in 2026. Advanced infrastructure, specialized medical personnel, intensive care units, and cardiology departments contribute to strong adoption in these facilities.
At the same time, homecare settings are expected to record a 7.9% CAGR during the forecast period, reflecting the growing shift toward decentralized cardiac care.
Regional Outlook for the Market
North America dominated the global market with a 38.29% share in 2025. The regional market is projected to reach USD 3.14 billion in 2026. Advanced healthcare infrastructure, high adoption of remote patient monitoring, and substantial critical-care capacity are supporting regional growth.
The U.S. remains a major contributor. Its market is projected to reach USD 3.09 billion in 2026, representing approximately 34.9% of global revenue.
Europe is expected to register a 6.9% CAGR during the forecast period and reach approximately USD 2.92 billion in 2026.
The increasing adoption of non-invasive and wearable monitoring technologies for chronic disease management is supporting demand across the region. Germany and the U.K. are among the important national markets.
Asia Pacific is projected to become the third-largest regional market, reaching approximately USD 1.68 billion in 2026.
Growing awareness of early diagnosis, increasing cardiovascular disease prevalence, and expanding remote monitoring capabilities are contributing to market development.
Japan's market is projected to generate approximately USD 0.27 billion in 2026, while China's market is expected to reach nearly USD 0.62 billion. India's market is projected to reach approximately USD 0.24 billion in 2026.
Latin America and the Middle East & Africa
Latin America and the Middle East & Africa are expected to experience moderate growth. Increasing healthcare investment, expanding cardiac care infrastructure, and rising demand for advanced monitoring technologies are creating opportunities in these regions.
The Latin American market is projected to reach approximately USD 0.54 billion in 2026, while the GCC market is expected to reach USD 0.19 billion.
Challenges Facing the Market
High Cost of Implantable Devices
The cost of implantable monitoring technologies remains a major barrier, particularly in low- and middle-income countries.
Implantable systems may require specialized clinical expertise, hospital infrastructure, and follow-up care, which can restrict adoption in areas with limited healthcare resources.
Data Management and Patient Compliance
Continuous monitoring generates significant volumes of patient data. Healthcare organizations need suitable IT infrastructure, trained personnel, and effective data-management systems to process this information.
False alerts can also increase workload for healthcare professionals. Patient compliance represents another challenge, particularly for elderly users who may find connected digital technologies difficult to operate consistently.
The competitive environment is characterized by product innovation, clinical validation, digital integration, and expansion of cardiac care portfolios.
According to Fortune Business Insights, Abbott, Medtronic, and Boston Scientific Corporation held major market shares in 2025. Their strong cardiac portfolios, international presence, and focus on product innovation contribute to their market positions.
Other prominent companies profiled in the market include BIOTRONIK, Koninklijke Philips N.V., GE HealthCare, ZOLL Medical Corporation, iRhythm Technologies, Qardio, Inc., and CardiacSense.
Companies are increasingly focusing on wearable technologies, non-invasive monitoring, remote patient monitoring, and digital integration to address the changing needs of healthcare providers and patients.
Future Outlook for Heart Failure Monitoring Devices
The future of the market will increasingly revolve around connected, predictive, and patient-friendly monitoring technologies.
AI-powered analytics could help healthcare providers interpret complex patient data more efficiently. Wearable technologies may enable continuous monitoring outside hospitals, while cloud-based platforms can facilitate communication between patients and care teams.
The increasing adoption of home-based healthcare is also expected to create opportunities for manufacturers that can combine accuracy, comfort, connectivity, and affordability.
As healthcare systems prioritize earlier intervention and reduced hospital utilization, monitoring devices are likely to become an increasingly important component of long-term heart failure management.
The global heart failure monitoring devices market is projected to increase from USD 8.84 billion in 2026 to USD 15.82 billion by 2034, representing a CAGR of 7.5%.
North America remains the leading regional market, while Asia Pacific presents significant growth potential due to its large cardiovascular patient population and expanding healthcare infrastructure.
Non-invasive monitoring is expected to remain highly attractive because of patient comfort and safety, while wearable devices and homecare monitoring are positioned for strong growth.
AI, predictive analytics, remote patient monitoring, cloud connectivity, and wearable technologies are expected to shape the next phase of market development.
Trending FAQs About Heart Failure Monitoring Devices Market
1. What is the size of the heart failure monitoring devices market in 2026?
According to Fortune Business Insights, the global heart failure monitoring devices market is projected to reach USD 8.84 billion in 2026.
2. What will the heart failure monitoring devices market be worth by 2034?
The market is projected to reach USD 15.82 billion by 2034, growing at a CAGR of 7.5% from 2026 to 2034.
3. Which segment dominates the heart failure monitoring devices market?
The external/non-wearable monitoring systems segment was the leading device type in 2025, while the non-invasive segment is estimated to hold an 85.2% share in 2026. Hospitals & ASCs are expected to account for 45.4% of the market by end user in 2026.
4. What is the biggest trend in the heart failure monitoring devices market?
The integration of AI and predictive analytics is a major emerging trend. These technologies can analyze multiple patient data points and support earlier identification of potential heart failure events.
5. Which region has the largest heart failure monitoring devices market share?
North America held the largest share of the global market in 2025, accounting for 38.29%. The region's advanced healthcare infrastructure and adoption of remote patient monitoring technologies are key factors supporting its leadership.
ย
Uncover Japanโs Market Trends - Explore the Latest - monitoring devices market- Insights